These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 11497426)

  • 21. Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells.
    Napier CE; Veas LA; Kan CY; Taylor LM; Yuan J; Wen VW; James A; O'Brien TA; Lock RB; MacKenzie KL
    Biochim Biophys Acta; 2010 Oct; 1803(10):1142-53. PubMed ID: 20619302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Arabidopsis splicing RNP variant STEP1 regulates telomere length homeostasis by restricting access of nuclease and telomerase.
    Yoo HH; Kwon C; Chung IK
    Mol Cells; 2010 Sep; 30(3):279-83. PubMed ID: 20803084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells.
    Goldkorn A; Blackburn EH
    Cancer Res; 2006 Jun; 66(11):5763-71. PubMed ID: 16740715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of telomerase limits the growth of human cancer cells.
    Hahn WC; Stewart SA; Brooks MW; York SG; Eaton E; Kurachi A; Beijersbergen RL; Knoll JH; Meyerson M; Weinberg RA
    Nat Med; 1999 Oct; 5(10):1164-70. PubMed ID: 10502820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.
    Zhang X; Mar V; Zhou W; Harrington L; Robinson MO
    Genes Dev; 1999 Sep; 13(18):2388-99. PubMed ID: 10500096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
    McChesney PA; Aisner DL; Frank BC; Wright WE; Shay JW
    Mol Cell Biol Res Commun; 2000 May; 3(5):312-8. PubMed ID: 10964756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development.
    Waki K; Anno K; Ono T; Ide T; Chayama K; Tahara H
    Cancer Sci; 2010 Jul; 101(7):1678-85. PubMed ID: 20456367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo regulation of telomerase activity and telomere length.
    Hathcock KS; Jeffrey Chiang Y; Hodes RJ
    Immunol Rev; 2005 Jun; 205():104-13. PubMed ID: 15882348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Telomere and telomerase in human cancer].
    Hiyama K; Hiyama E; Ishioka S; Yamakido M
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal heterogeneity in telomerase activity and telomere length in tumor-derived cell lines.
    Savre-Train I; Gollahon LS; Holt SE
    Proc Soc Exp Biol Med; 2000 Apr; 223(4):379-88. PubMed ID: 10721008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription.
    Ng LJ; Cropley JE; Pickett HA; Reddel RR; Suter CM
    Nucleic Acids Res; 2009 Mar; 37(4):1152-9. PubMed ID: 19129228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telomerase resets the homeostatic telomere length and prevents telomere dysfunction in immortalized human cells.
    McChesney PA; Turner KC; Jackson-Cook C; Elmore LW; Holt SE
    DNA Cell Biol; 2004 May; 23(5):293-300. PubMed ID: 15199944
    [No Abstract]   [Full Text] [Related]  

  • 34. Telomerase is an unusual RNA-containing enzyme. A review.
    Dokudovskaya SS; Petrov AV; Dontsova OA; Bogdanov AA
    Biochemistry (Mosc); 1997 Nov; 62(11):1206-15. PubMed ID: 9467844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells.
    Guiducci C; Anglana M; Wang A; Bacchetti S
    Exp Cell Res; 2001 May; 265(2):304-11. PubMed ID: 11302696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Telomeres and telomerase activity: their role in aging and in neoplastic development].
    Cottliar AS; Slavutsky IR
    Medicina (B Aires); 2001; 61(3):335-42. PubMed ID: 11474884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase.
    Sundararaj KP; Wood RE; Ponnusamy S; Salas AM; Szulc Z; Bielawska A; Obeid LM; Hannun YA; Ogretmen B
    J Biol Chem; 2004 Feb; 279(7):6152-62. PubMed ID: 14630908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of telomerase activity and telomere length to chemosensitivity.
    Kiyozuka Y
    Methods Mol Med; 2005; 111():97-108. PubMed ID: 15911975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomeric DNA: marker for human prostate cancer development?
    Ozen M; Imam SA; Datar RH; Multani AS; Narayanan R; Chung LW; von Eschenbach AC; Pathak S
    Prostate; 1998 Sep; 36(4):264-71. PubMed ID: 9719027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adding to the ends: what makes telomerase processive and how important is it?
    Lue NF
    Bioessays; 2004 Sep; 26(9):955-62. PubMed ID: 15351966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.